KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Depreciation & Amortization (CF): 2017-2025

Historic Depreciation & Amortization (CF) for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $176.0 million.

  • Elanco Animal Health's Depreciation & Amortization (CF) rose 3.53% to $176.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.0 million, marking a year-over-year increase of 0.15%. This contributed to the annual value of $662.0 million for FY2024, which is 4.61% down from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Depreciation & Amortization (CF) is $176.0 million, which was up 4.14% from $169.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Depreciation & Amortization (CF) registered a high of $202.0 million during Q1 2021, and its lowest value of $161.0 million during Q1 2025.
  • Its 3-year average for Depreciation & Amortization (CF) is $169.3 million, with a median of $170.0 million in 2024.
  • Over the last 5 years, Elanco Animal Health's Depreciation & Amortization (CF) had its largest YoY gain of 146.34% in 2021, and its largest YoY loss of 21.62% in 2021.
  • Elanco Animal Health's Depreciation & Amortization (CF) (Quarterly) stood at $174.0 million in 2021, then dropped by 3.45% to $168.0 million in 2022, then climbed by 1.79% to $171.0 million in 2023, then declined by 4.09% to $164.0 million in 2024, then increased by 3.53% to $176.0 million in 2025.
  • Its last three reported values are $176.0 million in Q3 2025, $169.0 million for Q2 2025, and $161.0 million during Q1 2025.